Medical Devices · Healthcare
CEO
2020-06-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Delcath Systems, Inc. publishes a filing, an earnings call transcript or a press release.
Get DCTH alertsJohn Purpura is recorded as CEO at Delcath Systems, Inc. (DCTH) since June 1, 2020. Delcath Systems, Inc. reported in an 8-K filed February 14, 2024 that John Purpura retired as Chief Operating Officer. The proxy statement of Delcath Systems, Inc. reports total compensation of $1,203,027 for John Purpura in fiscal 2023, including a base salary of $409,229. Disclosed compensation is on record for 6 fiscal years. John Purpura has spoken on 4 earnings calls across 1 company, most recently for Delcath Systems, Inc. on June 30, 2022. Delcath Systems, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Delcath Systems, Inc. includes Gerard Michel (CEO and Board Member), Sandra Pennell (CFO), Martha Rook (COO) and 7 others.
“On February 12, 2024, John Purpura notified Delcath Systems, Inc. (the “Company”) of his intent to retire as the Company’s Chief Operating Officer.”
“Regarding inventory preparations, we are closely monitoring the expiry dates for all components involved in HEPZATO KITS since this is a sterile product. We are carefully managing this and gathering launch quantities at the right time.”
“Yes, the ongoing work rolling up the CMC module has been ongoing, and it will be the subject of one of the first modules that we could submit to the FDA, along with non-clinical data from, say, module 4.”
“And thank you, Johnny for the detailed description of the clinical data compilation. So the clinical data compilation for the NDA is typically what's known as Module 5 of the NDA compilation.”
“I think what's novel about this technology can be summed up in three words. And you might have seen this in various incarnations in our prior communications, but the concept of isolation, saturation, and filtration, that's what's novel.”
2020-06-01–present
Start not stated–2020-10-01
Start not stated–2024-02-12
Start not stated–2024-02-14
Medical Devices · Healthcare
CEO
2020-06-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Delcath Systems, Inc. (DCTH) | M.S. Chief Operating Officer | $409,229 | $1,203,027 |
| 2022 | Delcath Systems, Inc. (DCTH) | M.S. Chief Operating Officer | $396,136 | $804,328 |
| 2021 | Delcath Systems, Inc. (DCTH) | Chief Operating Officer | $386,823 | $925,489 |
| 2020 | Delcath Systems, Inc. (DCTH) | Chief Operating Officer | $347,500 | $2,419,270 |
| 2019 | Delcath Systems, Inc. (DCTH) | Chief Operating Officer | $335,000 | $682,541 |
| 2018 | Delcath Systems, Inc. (DCTH) | M.S., Chief Operating Officer | $335,000 | $385,000 |